Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Deoxycytidine kinase (dCK) is one of the key enzymes of deoxynucleoside salvage supplying resting lymphocytes with DNA precursors for synthesis and repair. The level of dCK activity is especially important in chemotherapy with the use of deoxynucleoside analogues like arabinosyl cytosine (Citarabid, ara-C), or 2-chloro-deoxyadenosine (Cladribine, CdA). Previous results showed that Cladribine treatment of human lymphocytes increased several fold the activity of dCK without increasing the amount of dCK protein itself (Sasvári-Székely, et al., 1998, Biochem. Pharmacol. 56, 1175), and a possible post-translational modification was suggested. This theory was further investigated using NaF as an inhibitor of protein phosphatases. It was shown that NaF treatment of cells elevated dCK activity while inhibiting DNA synthesis. The possible mechanism of dCK activation/inactivation induced by exposure of cell cultures to different agents is discussed.

Original languageEnglish
Pages (from-to)251-256
Number of pages6
JournalActa Biochimica Polonica
Volume48
Issue number1
Publication statusPublished - 2001

Fingerprint

Deoxycytidine Kinase
Modulation
Cladribine
Lymphocytes
Salvaging
Chemotherapy
Phosphoprotein Phosphatases
Cytosine
DNA
Cytarabine
Post Translational Protein Processing
Cell culture
Repair
Cell Culture Techniques
Chemical activation
Cells
Drug Therapy
Enzymes
Therapeutics

Keywords

  • Deoxycytidine kinase
  • Lymphocytes
  • NaF
  • Tonsil

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

@article{a64693a5da384ede80accf3ecff3443b,
title = "Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF",
abstract = "Deoxycytidine kinase (dCK) is one of the key enzymes of deoxynucleoside salvage supplying resting lymphocytes with DNA precursors for synthesis and repair. The level of dCK activity is especially important in chemotherapy with the use of deoxynucleoside analogues like arabinosyl cytosine (Citarabid, ara-C), or 2-chloro-deoxyadenosine (Cladribine, CdA). Previous results showed that Cladribine treatment of human lymphocytes increased several fold the activity of dCK without increasing the amount of dCK protein itself (Sasv{\'a}ri-Sz{\'e}kely, et al., 1998, Biochem. Pharmacol. 56, 1175), and a possible post-translational modification was suggested. This theory was further investigated using NaF as an inhibitor of protein phosphatases. It was shown that NaF treatment of cells elevated dCK activity while inhibiting DNA synthesis. The possible mechanism of dCK activation/inactivation induced by exposure of cell cultures to different agents is discussed.",
keywords = "Deoxycytidine kinase, Lymphocytes, NaF, Tonsil",
author = "Z. Csap{\'o} and M. Sasv{\'a}ri and T. Spasokoukotskaja and M. Staub",
year = "2001",
language = "English",
volume = "48",
pages = "251--256",
journal = "Acta Biochimica Polonica",
issn = "0001-527X",
publisher = "Acta Biochimica Polonica",
number = "1",

}

TY - JOUR

T1 - Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF

AU - Csapó, Z.

AU - Sasvári, M.

AU - Spasokoukotskaja, T.

AU - Staub, M.

PY - 2001

Y1 - 2001

N2 - Deoxycytidine kinase (dCK) is one of the key enzymes of deoxynucleoside salvage supplying resting lymphocytes with DNA precursors for synthesis and repair. The level of dCK activity is especially important in chemotherapy with the use of deoxynucleoside analogues like arabinosyl cytosine (Citarabid, ara-C), or 2-chloro-deoxyadenosine (Cladribine, CdA). Previous results showed that Cladribine treatment of human lymphocytes increased several fold the activity of dCK without increasing the amount of dCK protein itself (Sasvári-Székely, et al., 1998, Biochem. Pharmacol. 56, 1175), and a possible post-translational modification was suggested. This theory was further investigated using NaF as an inhibitor of protein phosphatases. It was shown that NaF treatment of cells elevated dCK activity while inhibiting DNA synthesis. The possible mechanism of dCK activation/inactivation induced by exposure of cell cultures to different agents is discussed.

AB - Deoxycytidine kinase (dCK) is one of the key enzymes of deoxynucleoside salvage supplying resting lymphocytes with DNA precursors for synthesis and repair. The level of dCK activity is especially important in chemotherapy with the use of deoxynucleoside analogues like arabinosyl cytosine (Citarabid, ara-C), or 2-chloro-deoxyadenosine (Cladribine, CdA). Previous results showed that Cladribine treatment of human lymphocytes increased several fold the activity of dCK without increasing the amount of dCK protein itself (Sasvári-Székely, et al., 1998, Biochem. Pharmacol. 56, 1175), and a possible post-translational modification was suggested. This theory was further investigated using NaF as an inhibitor of protein phosphatases. It was shown that NaF treatment of cells elevated dCK activity while inhibiting DNA synthesis. The possible mechanism of dCK activation/inactivation induced by exposure of cell cultures to different agents is discussed.

KW - Deoxycytidine kinase

KW - Lymphocytes

KW - NaF

KW - Tonsil

UR - http://www.scopus.com/inward/record.url?scp=0035227646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035227646&partnerID=8YFLogxK

M3 - Article

C2 - 11440177

AN - SCOPUS:0035227646

VL - 48

SP - 251

EP - 256

JO - Acta Biochimica Polonica

JF - Acta Biochimica Polonica

SN - 0001-527X

IS - 1

ER -